Tianyin Pharmaceutical (TPI) Reports Q1 Earnings of $0.05; Guides FY11 Revs

Tianyin Pharmaceutical (NYSE: TPI) reported Q1 EPS of $0.05, versus $0.11 reported last year. Revenue for the quarter came in at $17.5 million, versus $22 million reported last year.

Sees FY2012 revenue of $100 million, versus the consensus of $100.20 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
• JPMorgan Downgrades JD Logistics Inc (2618:HK) (JDLGF) to Neutral